Capital Calling: Vital Audio

Your voice can reveal more than words. But can a few seconds of speech become the next vital sign?

In this episode of Capital Calling, Nyamitse-Calvin Mahinda, Founder and CEO of Vital Audio, pitches a healthtech company turning ordinary voice recordings into clinical insights. Vital Audio is building AI-powered voice biomarker software that can extract signals like heart rate, heart rate variability, rhythm, respiratory metrics, and other physiological indicators from short voice samples, without requiring wearables, apps, or new hardware. Its platform, Sonometrik, is designed to turn any phone into a low-friction tool for remote patient monitoring and patient screening.

Across the table, investors René Bastón of Covenant Venture Capital, Sabriya Stukes, PhD of SOSV, and Doug Hayes of Junto Health & Hubble engage with the pitch as it unfolds. They assess whether voice biomarkers can be clinically trusted, how Vital Audio can navigate healthcare adoption and regulation, whether its AI models are defensible, and whether voice-based monitoring can scale into a venture-backed infrastructure layer for remote care.

Produced by Coeus Collective in partnership with the NYU Stern Berkley Center for Entrepreneurship, Capital Calling offers founders, operators, students, and investors an unfiltered look at how early-stage investment decisions actually happen, and what separates compelling ideas from fundable companies. Founders pitch live. Investors decide.

Watch Now on YouTube

Watch or Listen Now on Spotify

Listen Now on Apple Podcasts